Skip to main content
Erschienen in: Esophagus 4/2019

18.05.2019 | Original Article

Ivor–Lewis esophagectomy for patients with squamous cell carcinoma of the thoracic esophagus with a history of total pharyngolaryngectomy

verfasst von: Keita Takahashi, Shinji Mine, Ryotaro Kozuki, Tasuku Toihata, Akihiko Okamura, Yu Imamura, Masayuki Watanabe

Erschienen in: Esophagus | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Synchronous or metachronous esophageal, and head and neck cancers are often observed, and we occasionally encounter esophageal cancer cases with a past history of total pharyngolaryngectomy (TPL) for head and neck cancers. Total esophagectomy after TPL may impair blood supply to the trachea and may cause tracheal necrosis. Meanwhile, Ivor–Lewis esophagectomy can prevent the above-mentioned risks, but there is a concern about an anastomosis with the remnant upper esophagus that lost blood supply after two surgical procedures. The surgical outcomes of Ivor–Lewis esophagectomy after TPL remain unclear. Therefore, we investigated the surgical outcomes.

Methods

This study included patients who underwent Ivor–Lewis esophagectomy for esophageal cancer with a history of TPL at our institution between 2005 and 2017. We retrospectively investigated the patients’ background characteristics and short-term surgical outcomes.

Results

Twelve consecutive patients (8 men and 4 women) were included in this study. The median period between TPL and esophagectomy was 32 months (range 2–185 months). All patients underwent esophagectomy via right open thoracotomy and reconstruction using a gastric tube with intrathoracic anastomosis. Although the esophagogastric anastomosis was made on the remnant upper esophagus, which had already lost blood supply from the inferior thyroid artery, there was no case of anastomotic leakage or esophageal necrosis, and hospital mortality was not observed.

Conclusion

Ivor–Lewis esophagectomy for patients with a history of TPL is a safe procedure, which can prevent severe complications including anastomotic leakage or tracheal necrosis.
Literatur
1.
Zurück zum Zitat Tachimori Y, et al. Treatment for synchronous and metachronous carcinomas of the head and neck and esophagus. J Surg Oncol. 1990;45(1):43–5.CrossRefPubMed Tachimori Y, et al. Treatment for synchronous and metachronous carcinomas of the head and neck and esophagus. J Surg Oncol. 1990;45(1):43–5.CrossRefPubMed
2.
Zurück zum Zitat Yoshino K, et al. Diagnosis and treatment of metachronous cancers in the esophagus and the head and neck region. J Surg Oncol. 1995;58(4):246–51.CrossRefPubMed Yoshino K, et al. Diagnosis and treatment of metachronous cancers in the esophagus and the head and neck region. J Surg Oncol. 1995;58(4):246–51.CrossRefPubMed
3.
Zurück zum Zitat Diseases JSOE. Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus. 2005;2(2):43–69.CrossRef Diseases JSOE. Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus. 2005;2(2):43–69.CrossRef
4.
Zurück zum Zitat Lim H, et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver. 2015;9(2):159–65.CrossRefPubMed Lim H, et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver. 2015;9(2):159–65.CrossRefPubMed
5.
Zurück zum Zitat Shiozaki H, et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer. 1990;66(10):2068–71.CrossRefPubMed Shiozaki H, et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer. 1990;66(10):2068–71.CrossRefPubMed
7.
Zurück zum Zitat Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 2010;116(22):5336–9.CrossRefPubMed Sobin LH, Compton CC. TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 2010;116(22):5336–9.CrossRefPubMed
8.
Zurück zum Zitat Liebermann-Meffert DM, et al. Esophagectomy without thoracotomy: is there a risk of intramediastinal bleeding? A study on blood supply of the esophagus. Ann Surg. 1987;206(2):184–92.CrossRefPubMedPubMedCentral Liebermann-Meffert DM, et al. Esophagectomy without thoracotomy: is there a risk of intramediastinal bleeding? A study on blood supply of the esophagus. Ann Surg. 1987;206(2):184–92.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Suga H, et al. Free jejunal transfer for patients with a history of esophagectomy and gastric pull-up. Ann Plast Surg. 2007;58(2):182–5.CrossRefPubMed Suga H, et al. Free jejunal transfer for patients with a history of esophagectomy and gastric pull-up. Ann Plast Surg. 2007;58(2):182–5.CrossRefPubMed
11.
Zurück zum Zitat Fujiki M, et al. Risk factors for tracheal necrosis after total pharyngolaryngectomy. Head Neck. 2015;37(8):1207–10.CrossRefPubMed Fujiki M, et al. Risk factors for tracheal necrosis after total pharyngolaryngectomy. Head Neck. 2015;37(8):1207–10.CrossRefPubMed
12.
Zurück zum Zitat Matsumoto A, et al. Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck: a retrospective study. World J Surg. 2016;40(2):388–94.CrossRefPubMed Matsumoto A, et al. Efficacy of staged treatment strategy for patients with synchronous double cancers of the esophagus and head and neck: a retrospective study. World J Surg. 2016;40(2):388–94.CrossRefPubMed
Metadaten
Titel
Ivor–Lewis esophagectomy for patients with squamous cell carcinoma of the thoracic esophagus with a history of total pharyngolaryngectomy
verfasst von
Keita Takahashi
Shinji Mine
Ryotaro Kozuki
Tasuku Toihata
Akihiko Okamura
Yu Imamura
Masayuki Watanabe
Publikationsdatum
18.05.2019
Verlag
Springer Singapore
Erschienen in
Esophagus / Ausgabe 4/2019
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-019-00677-w

Weitere Artikel der Ausgabe 4/2019

Esophagus 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.